冠华国际控股(00539.HK)附属福源国际拟6300万港元出售香港写字楼物业
格隆汇7月15日丨冠华国际控股(00539.HK)公告,于2019年7月15日,公司非全资附属福源国际有限公司为卖方与买方宝陞国际有限公司订立该协议,买方拟向卖方收购该等物业,即香港的一个写字楼及四个停车位,代价合共为6300万港元。待出售事项完成后,写字楼的现有租约将告终止。
买方为于香港注册成立的有限公司及Jerash的全资附属公司。于公布日期,蔡间接持有Jerash约38.01%的普通股,而Jerash则全资拥有买方。买方主要从事买卖成衣制品及向Jerash及其附属公司提供行政支援。
经扣减所有相关费用及开支后,预期自出售事项所得款项净额将保留作集团成衣业务的一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.